The analysis of day-to-day glucose excursions when switching from biphasic insulin 30 to insulin degludec and aspart

The analysis of day-to-day glucose excursions when switching from biphasic insulin 30 to insulin degludec and aspart - Switching from biphasic insulin 30 to insulin degludec and aspart

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021939

Enrollment

Registered

2016-04-18

Start date

2016-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with type 2 diabetes using biphasic insulin 30

Exclusion criteria

Exclusion criteria: patients who cannnot mesure blood glucose

Design outcomes

Primary

Measure	Time frame
day-to-day glucose excursions caluculated from patients self glucose mesuring over a month in both insulin periods	—

Countries

Japan

Contacts

Public ContactKanta Fujimoto

Kobe City Medical Center General Hospital Internal Medicine of Diabetes and Endocrinology

kantachi@kcho.jp075-302-4321

Outcome results